Company Egalet Corp Nasdaq
Equities
US28226B1044
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Smith
CEO | Chief Executive Officer | 55 | 19-10-22 |
Daniel Peisert
DFI | Director of Finance/CFO | 49 | 20-05-19 |
Comptroller/Controller/Auditor | 49 | 13-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Todd Smith
CEO | Chief Executive Officer | 55 | 19-10-22 |
Daniel Peisert
DFI | Director of Finance/CFO | 49 | 20-05-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,611,957 | 8,680,163 ( 90.31 %) | 0 | 90.31 % |
Company contact information
![address Egalet Corp](https://cdn.zonebourse.com/static/address/15724811.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+24.14% | 47.07B | |
+46.45% | 42.06B | |
-3.07% | 39.98B | |
+37.52% | 33.02B | |
-6.30% | 27.9B | |
+19.20% | 27.63B | |
+47.80% | 14.37B | |
+44.47% | 13.45B | |
+1.17% | 12.03B |